Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non–small cell lung carcinomas

World Health Organization Classification of Tumours

CDM Fletcher, Anke van den Berg, Ineke Molenaar · 2002 · 7.1K citations

Medicine, Oncology, Pathology +11

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Masahiro Fukuoka, Seiji Yano, Giuseppe Giaccone et al. · Journal of Clinical Oncology · 2003 · 2.9K citations

Medicine, Oncology, Pharmacology +13

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst et al. · JAMA · 2003 · 2.5K citations

Medicine, Oncology, Pharmacology +17

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

Annie Yang, Ronen Schweitzer, Deqin Sun et al. · Nature · 1999 · 2.2K citations

Life Sciences, Cell Biology, Developmental Biology +13

p63 is a p53 homologue required for limb and epidermal morphogenesis

Alea A. Mills, Binhai Zheng, Xiao‐Jing Wang et al. · Nature · 1999 · 2K citations

Life Sciences, Genetics, Molecular Genetics +14